article thumbnail

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

European Pharmaceutical Review

New research published in JAMA Health Forum has documented that the US National Institutes of Health (NIH) spent $8.1 billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. This was ~10 percent of reported industry spending. billion (3.3

article thumbnail

Whole genome sequencing and analysis of live biotherapeutic products

European Pharmaceutical Review

1 The European Directorate for the Quality of Medicines & Healthcare (EDQM) also accepted LBP as a new category of medicinal products for the European market in 2019. Therefore, characterisation of the microorganism(s) is of utmost importance to LBP quality documentation. Download and read more now… .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Enabling More Efficient and Effective C&Q Through GEP

ISPE

was published in 2019, most of the attention was focused on the incorporation of quality risk management (QRM) into the integrated commissioning and qualification (C&Q) approach. Appropriate ECM and document management ensures that proposed changes are identified, assessed for impact, implemented, and verified. Chip Bennett, PMP.

article thumbnail

GPhC fails to meet timeliness standard for fitness to practise cases for fifth consecutive year

Hospital Pharmacy Europe

This was significantly more than the previous year, and follows a steady increase since 2019. This article was originally published by our sister publication The Pharmacist. It said that this was driven by ‘a sharp increase in concerns raised by members of the public’.

article thumbnail

GAMP 5 update: computerized system expectations for pharma manufacturers

European Pharmaceutical Review

Validation projects have often been documentation-focused exercises, more befitting a grammar exercise than artifacts supportive of regulated activity. This article primarily discusses Appendix D5 Testing of Computerized Systems and Appendix M12 Critical Thinking. The GAMP 5 Second Edition includes: Six completely new appendices.

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

For changes requiring approval before implementation, once the necessary information has been submitted across regions, each health authority must review the data package and documentation based on local requirements. laboratory notebooks, batch records, and technical reports) to submission documents (e.g.,

article thumbnail

GPhC fails to meet timeliness standard for fitness to practise cases for fifth consecutive year

Hospital Pharmacy Europe

This was significantly more than the previous year, and follows a steady increase since 2019. This article was originally published by our sister publication The Pharmacist. It said that this was driven by ‘a sharp increase in concerns raised by members of the public’.